FIREBRICK PHARMA LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.052 AUD | -1.89% |
|
+1.96% | +4.00% |
| 13/06 | Firebrick Pharma Launches Nasodine Nasal Spray in Singapore | MT |
| 23/05 | Firebrick Pharma Obtains Nasodine Composition Patent in South Africa | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 6.88M | - | - | - | - | - | |
| 823B | ||||||
| 641B | ||||||
| 352B | - | - | - | - | ||
| 324B | ||||||
| 301B |
